GAM Holding’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-34,544
Closed -$1.57M 370
2020
Q3
$1.57M Hold
34,544
0.09% 220
2020
Q2
$1.56M Hold
34,544
0.1% 217
2020
Q1
$1.33M Hold
34,544
0.09% 216
2019
Q4
$1.6M Hold
34,544
0.08% 255
2019
Q3
$1.41M Hold
34,544
0.06% 314
2019
Q2
$1.66M Buy
34,544
+17,800
+106% +$936K 0.07% 326
2019
Q1
$1.05M Buy
+16,744
New +$1.15M 0.04% 412

Other funds holding BEAT

GAM Holding's BEAT Position: Q4 2020 in Review

GAM Holding sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 34,544 shares — an estimated $1.57M sold.

GAM Holding first reported a position in BEAT in Q1 2019 and held it in 7 quarters. The position peaked at $1.66M in Q2 2019. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • GAM Holding reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • GAM Holding sold 34,544 BioTelemetry, Inc. shares in Q4 2020, an estimated $1.57M.
  • GAM Holding first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 7 quarters.
  • GAM Holding's BioTelemetry, Inc. position peaked at $1.66M in Q2 2019.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on GAM Holding's 13F filing for Q4 2020, filed 10 Feb 2021.